Narlumosbart Antibody
Narlumosbart (JMT103) is a human IgG4κ monoclonal antibody designed to specifically target RANKL. It is utilized in research to investigate bone metabolism disorders, including osteoporosis and bone metastasis, through both in vitro binding assays and in vivo preclinical models.
Product Specifications
Target
RANKL/RANK
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Signal Transduction
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
